Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
ANNALS OF SURGICAL ONCOLOGY. Bd. 31. H. 1. 2024 S. S44-S45
Erscheinungsjahr: 2024
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Janjigian, Yelena Y. (Autor)
Al-Batran, Salah-Eddin (Autor)
Wainberg, Zen A. (Autor)
Van Cutsem, Eric (Autor)
Molena, Daniela (Autor)
Muro, Kei (Autor)
Hyung, Woo Jin (Autor)
Wyrwicz, Lucjan (Autor)
Oh, Do-Youn (Autor)
Omori, Takeshi (Autor)
Moehler, Markus (Autor)
Garrido, Marcelo (Autor)
Oliveira, Sulene C. S. (Autor)
Liberman, Moishe (Autor)
Oliden, Victor C. (Autor)
Bilici, Mehmet (Autor)
Kurland, John (Autor)
Xynos, Ioannis (Autor)
Mann, Helan (Autor)
Tabernero, Josep (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
